| Erika Sutton, PT | |
|
611 W Hwy 6, Suite 101, Waco, TX 76710-7544 | |
| (254) 776-3070 | |
| (254) 776-7909 |
| Full Name | Erika Sutton |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 14 Years |
| Location | 611 W Hwy 6, Waco, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114235546 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2251X0800X | Physical Therapist - Orthopedic | 1200372 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Active Therapy Group Llc | 0648636597 | 6 |
News Archive
Marken confirmed today that their global cold chain network will be expanded to respond to the growing need for just in time conditioning and preparation of temperature controlled packaging solutions.
Researchers presented data today on ARQ 092, an AKT inhibitor in Phase 1 clinical development by ArQule, Inc. at the AACR Annual Meeting held in Washington, D.C., April 6-10, showing that this novel, oral agent inhibits the AKT pathway and has a manageable safety profile in an ongoing Phase 1 clinical trial.
Online drug sales in 2006 from Canadian pharmacies to U.S. consumers dropped about 50%, from $420 million Canadian dollars in 2005 to $211 million Canadian dollars last year, according to data from IMS Health, the Philadelphia Inquirer reports.
Cellectis, the French genome engineering specialist, has announced today that it has acquired all the assets of Cyto Pulse Sciences Inc., a US-based company specializing in the development, manufacture and commercialization of electroporation technology and equipment.
Data from the EVOLVE Short DAPT study found that shortened three-month dual antiplatelet therapy did not increase myocardial infarction or stent thrombosis in high bleeding risk patients treated with a contemporary drug-eluting stent.
› Verified 3 days ago
| Provider Name | Active Sports Physical Therapy Pllc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1053879353 PECOS PAC ID: 6709127954 Enrollment ID: O20190416002155 |
News Archive
Marken confirmed today that their global cold chain network will be expanded to respond to the growing need for just in time conditioning and preparation of temperature controlled packaging solutions.
Researchers presented data today on ARQ 092, an AKT inhibitor in Phase 1 clinical development by ArQule, Inc. at the AACR Annual Meeting held in Washington, D.C., April 6-10, showing that this novel, oral agent inhibits the AKT pathway and has a manageable safety profile in an ongoing Phase 1 clinical trial.
Online drug sales in 2006 from Canadian pharmacies to U.S. consumers dropped about 50%, from $420 million Canadian dollars in 2005 to $211 million Canadian dollars last year, according to data from IMS Health, the Philadelphia Inquirer reports.
Cellectis, the French genome engineering specialist, has announced today that it has acquired all the assets of Cyto Pulse Sciences Inc., a US-based company specializing in the development, manufacture and commercialization of electroporation technology and equipment.
Data from the EVOLVE Short DAPT study found that shortened three-month dual antiplatelet therapy did not increase myocardial infarction or stent thrombosis in high bleeding risk patients treated with a contemporary drug-eluting stent.
› Verified 3 days ago
| Provider Name | Active Therapy Group Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326745647 PECOS PAC ID: 0648636597 Enrollment ID: O20230518001368 |
News Archive
Marken confirmed today that their global cold chain network will be expanded to respond to the growing need for just in time conditioning and preparation of temperature controlled packaging solutions.
Researchers presented data today on ARQ 092, an AKT inhibitor in Phase 1 clinical development by ArQule, Inc. at the AACR Annual Meeting held in Washington, D.C., April 6-10, showing that this novel, oral agent inhibits the AKT pathway and has a manageable safety profile in an ongoing Phase 1 clinical trial.
Online drug sales in 2006 from Canadian pharmacies to U.S. consumers dropped about 50%, from $420 million Canadian dollars in 2005 to $211 million Canadian dollars last year, according to data from IMS Health, the Philadelphia Inquirer reports.
Cellectis, the French genome engineering specialist, has announced today that it has acquired all the assets of Cyto Pulse Sciences Inc., a US-based company specializing in the development, manufacture and commercialization of electroporation technology and equipment.
Data from the EVOLVE Short DAPT study found that shortened three-month dual antiplatelet therapy did not increase myocardial infarction or stent thrombosis in high bleeding risk patients treated with a contemporary drug-eluting stent.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erika Sutton, PT 611 W Highway 6 Ste 101, Waco, TX 76710-7545 Ph: (254) 776-3070 | Erika Sutton, PT 611 W Hwy 6, Suite 101, Waco, TX 76710-7544 Ph: (254) 776-3070 |
News Archive
Marken confirmed today that their global cold chain network will be expanded to respond to the growing need for just in time conditioning and preparation of temperature controlled packaging solutions.
Researchers presented data today on ARQ 092, an AKT inhibitor in Phase 1 clinical development by ArQule, Inc. at the AACR Annual Meeting held in Washington, D.C., April 6-10, showing that this novel, oral agent inhibits the AKT pathway and has a manageable safety profile in an ongoing Phase 1 clinical trial.
Online drug sales in 2006 from Canadian pharmacies to U.S. consumers dropped about 50%, from $420 million Canadian dollars in 2005 to $211 million Canadian dollars last year, according to data from IMS Health, the Philadelphia Inquirer reports.
Cellectis, the French genome engineering specialist, has announced today that it has acquired all the assets of Cyto Pulse Sciences Inc., a US-based company specializing in the development, manufacture and commercialization of electroporation technology and equipment.
Data from the EVOLVE Short DAPT study found that shortened three-month dual antiplatelet therapy did not increase myocardial infarction or stent thrombosis in high bleeding risk patients treated with a contemporary drug-eluting stent.
› Verified 3 days ago
Dr. Paul Cook, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4800 Memorial Dr, Waco, TX 76711 Phone: 254-752-6581 | |
Julia Elizabeth Bennett, P. T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 611 W State Highway 6, Suite 101, Waco, TX 76710 Phone: 254-776-3070 Fax: 254-776-7909 | |
Mrs. Lori M Anderson, PT-MS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6600 Fish Pond Rd, Suite 204, Waco, TX 76710 Phone: 254-741-8450 | |
Dr. Justin Deshaun Slaughter, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6600 Fish Pond Rd, Waco, TX 76710 Phone: 254-741-8450 | |
Neil B Meske, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 611 W State Highway 6, Suite 101, Waco, TX 76710 Phone: 254-776-3070 Fax: 254-776-7909 | |
F Scott Feil, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1201 Mesa Verde Dr, Waco, TX 76712 Phone: 631-523-6337 | |
Provision Therapy, Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5901 Crosslake Pkwy, Waco, TX 76712 Phone: 847-565-9156 |